CNR2 and early-onset autosomal dominant Alzheimer disease: The CB2 can be upregulated in multiple central nervous system diseases, such as Alzheimer's disease, Parkinson's disease, Huntington's disease, and stroke (Capettini et al., 2012; Javed et al., 2016).